BIIB vs TNDM · P/E 21, rev $9.89B vs rev $501.8M
Biogen Inc (BIIB) versus Tandem Diabetes Care Inc (TNDM) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Tandem Diabetes Care Inc (TNDM) is a medical devices company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TNDM revenue for 2026-06-30 was $501.8M. Net income was -$41.6M. TNDM currently screens at market cap $1.06B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TNDM currently screens at market cap $1.06B.
Not investment advice. Open the BIIB and TNDM stock pages for the full models.
Not investment advice.